The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease | Zendy

Kristin L. Nichol | Zendy; Leslie Baken | Zendy; J. Wuorenma | Zendy; Andrew Nelson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease

Author(s) -

Kristin L. Nichol,

Leslie Baken,

J. Wuorenma,

Andrew Nelson

Publication year - 1999

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.159.20.2437

Subject(s) - medicine , vaccination , pneumococcal pneumonia , pneumonia , pneumococcal vaccine , confidence interval , pneumococcal infections , influenza vaccine , population , cohort study , relative risk , cohort , retrospective cohort study , pediatrics , streptococcus pneumoniae , immunology , environmental health , biology , bacteria , genetics

More than 50% of the elderly population has not received pneumococcal vaccination. Uncertainty regarding the benefits of immunization, particularly for noninvasive disease, may contribute to the underuse of pneumococcal vaccine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research